Dr. Agarwal’s Eye Hospital Limited has announced a major corporate restructuring through its Amalgamation with Dr. Agarwal’s Health Care Limited.
The Hon’ble National Company Law Tribunal (NCLT), Chennai Bench, has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited (Transferor Company) and Dr. Agarwal’s Health Care Limited (Transferee Company).
The company has confirmed that the scheme will become effective from November 1, 2026, following the filing of the NCLT order with the Registrar of Companies.
Here’s what it means for shareholders:
Eligible shareholders of Dr. Agarwal’s Eye Hospital Limited will receive equity shares of Dr. Agarwal’s Health Care Limited in exchange for their existing shares.
Record Date: November 18, 2026
Share Exchange Ratio:
23 fully paid-up equity shares of Dr. Agarwal’s Health Care Limited (Face Value ₹1 each)
for every 2 fully paid-up equity shares of Dr. Agarwal’s Eye Hospital Limited (Face Value ₹10 each).
Appointed Date: April 1, 2026
Scheme Effective Date: November 1, 2026
NCLT Order Date: September 30, 2026
Record Date: November 18, 2026
Post-Merger Status:
-
Dr. Agarwal’s Eye Hospital Limited will stand dissolved without being wound up.
-
Dr. Agarwal’s Health Care Limited will continue as the transferee company.
What changes for investors:
Shareholders of Dr. Agarwal’s Eye Hospital Limited whose names appear in the company’s records as on the Record Date, November 18, 2026, will be entitled to receive shares of Dr. Agarwal’s Health Care Limited in the approved exchange ratio of 23:2.
Upon the scheme becoming effective on November 1, 2026, the Board of Directors of Dr. Agarwal’s Eye Hospital Limited will cease to exist, and the company will stand dissolved without winding up.
This amalgamation is aimed at:
-
Consolidating the businesses of Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited under a unified corporate structure.
-
Streamlining corporate operations and governance.
-
Enabling greater operational integration between the two entities.
-
Creating long-term value for shareholders through the amalgamated business.